Showing 1621-1630 of 4065 results for "".
Targeting Macrophages in Pulmonary Arterial Hypertension
https://reachmd.com/programs/clinicians-roundtable/targeting-macrophages-in-pulmonary-arterial-hypertension/56327/Hidden HFpEF in Atrial Fibrillation: A Missed Diagnosis with Real Consequences
https://reachmd.com/programs/heart-matters/hidden-hfpef-atrial-fibrillation-consequences/54804/Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
https://reachmd.com/programs/cme/tbd/37671/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.The Critical Interplay: CKD, HF, and HyperkaleAmia
https://reachmd.com/programs/cme/the-critical-interplay-ckd-hf-and-hyperkalemia/36193/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
https://reachmd.com/programs/cme/tbd/37670/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Potassium Binders in Practice: Clinical Trial Evidence
https://reachmd.com/programs/cme/tbd/37672/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Potassium Binders: Safety Comes First!
https://reachmd.com/programs/cme/tbd/37673/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
https://reachmd.com/programs/cme/tbd/37674/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
https://reachmd.com/programs/cme/tbd/36194/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Future Directions in Managing Hyperkalemia in CKD and HF
https://reachmd.com/programs/cme/tbd/37676/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.